1887

Abstract

In ∼ 10% of natural human immunodeficiency virus 1 (HIV-1) gene populations, sequences of shortened open reading frames with premature stop codons have been found. Here we report the functional analysis of two patient-derived genes. 45-2 encodes a C terminally truncated Vif protein of only 173 instead of 192 amino acids and additionally contains several rare amino acid substitutions which are in part shared by A65-5. HIV-1 pNL4-3-derived recombinant A45-2 and A65-5 virions were fully infectious in H9 cells and human PBMC, both known to be non-permissive for -defective HIV-1. Furthermore, A45-2 virions produced in primary human monocyte-derived macro-phages were infectious for MT-4 cells. This study unequivocally demonstrates that the C-terminal region (19 amino acids) of the Vif protein is dispensable for Vif function in the cell culture systems employed. Additionally, we investigated whether the Vif protein might be phosphorylated and obtained no evidence for this.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-7-1389
1996-07-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/7/JV0770071389.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-7-1389&mimeType=html&fmt=ahah

References

  1. Bairoch A. 1992; PROSITE: a dictionary of sites and patterns in proteins. Nucleic Acids Research 20:2013–2018
    [Google Scholar]
  2. Borman A. M., Quillent C., Charneau P., Dauguet C., Clavel F. 1995; Human immunodeficiency virus type I vif-mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. Journal of Virology 69:2058–2067
    [Google Scholar]
  3. Bosch V., Pawlita M. 1990; Mutational analysis of the human immunodeficiency virus type I env gene product proteolytic cleavage site. Journal of Virology 64:2337–2344
    [Google Scholar]
  4. Courcoul M., Patience C., Rey F., Blanc D., Harmache A., Sire J., Vigne R., Spire B. 1995; Peripheral blood mononuclear cells produce normal amounts of defective vif- human immunodeficiency virus type I particles which are restricted for the preretrotranscriptional steps. Journal of Virology 69:2086–2074
    [Google Scholar]
  5. Freed E., Martin M. A. 1994; HIV-1 infection in non-dividing cells. Nature 369:107–108
    [Google Scholar]
  6. Gabuzda D. H., Li H., Lawrence K., Vasir B. S., Crawford K., Langhoff E. 1994; Essential role of vif in establishing productive HIV-1 infections in peripheral blood T lymphocytes and monocytes/ macrophages. Journal of Acquired Immune Deficiency Syndromes 7:908–915
    [Google Scholar]
  7. Garret E. D., Tiley L. S., Cullen B. R. 1991; Rev activates expression of the human immunodeficiency virus type I vif and vpr gene products. Journal of Virology 65:1653–1657
    [Google Scholar]
  8. Goncalves J., Jallepalli P., Gabuzda D.H. 1994; Subcellular localization of the Vif protein of human immunodeficiency virus type 1. Journal of Virology 68:704–712
    [Google Scholar]
  9. Goncalves J., Shi B., Yang X., Gabuzda D. 1995; Biological activity of human immunodeficiency virus type I Vif requires membrane targeting by C-terminal basic domains. Journal of Virology 69:7196–7204
    [Google Scholar]
  10. Kawamura M., Ishizaki T., Ishimoto A., Shioda T., Kitamura T., Adachi A. 1994; Growth ability of human immunodeficiency virus type I auxiliary gene mutants in primary blood macrophage cultures. Journal of General Virology 75:2427–2431
    [Google Scholar]
  11. Lindner D., Geschwendt M., Marks F. 1992; Phorbol ester-induced down-regulation of the 80-kD myristoylated alanine-rich C-kinase substrate related protein in Swiss 3T3 fibroblasts. Journal of Biological Chemistry 267:24–26
    [Google Scholar]
  12. Michaels F. H., Hattori N., Gallo R. C., Franchini G. 1993; The human immunodeficiency virus type I (HIV-1) Vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2. AIDS Research and Human Retroviruses 9:1025–1030
    [Google Scholar]
  13. Myers G., Wain-Hobson S., Henderson L. E., Korber B., Jeang K.-T., Pavlakis G. N. (Editors) 1994; Human Retroviruses and AIDS. Los Alamos National Laboratory; Los Alamos, New Mexico:
    [Google Scholar]
  14. Perno C.-F., Yarchoan R. 1991; Culture of HIV in monocytes and macrophages. In Current Protocols in Immunology vol 2 unit 12.4.3–12.4.4. Edited by Coligan J. E. Kruisbeek A. M., Margulies D. H., Shevach E. M., Strobber W. New York: John Wiley;
    [Google Scholar]
  15. Poli G., Fauci A. S. 1991; Isolation and quantitation of HIV in peripheral blood. In Current Protocols in Immunology vol 2 unit 12.2.2. Edited by Coligan J. E. Kruisbeek A. M., Margulies D. H., Shevach E. M., Strobber W. New York: John Wiley;
    [Google Scholar]
  16. Sczakiel G., Oelze I., Rittner K. 1993; Microinjection: a technique to study inhibition of HIV-I replication mediated by antisense RNA and parvovirus genes. In Biotechnology Applications of Microinjection, Microscopic Imaging, and Fluorescence pp 1–10 Edited by Bach P., Reynolds C. H., Clark J. M., Poole P., Mottley J. New York: Plenum Press;
    [Google Scholar]
  17. Sova P., Van Ranst M., Gupta P., Balachandran R., Chao W., Itescu S., McKinley G., Volsky D. J. 1995; Conservation of an intact human immunodeficiency virus type I vif gene in vitro and in vivo. Journal of Virology 69:2557–2564
    [Google Scholar]
  18. Subbramanian R. A., Cohen E. A. 1994; Molecular biology of the human immunodeficiency vims accessory proteins. Journal of Virology 68:6831–6835
    [Google Scholar]
  19. Wieland U., Kratschmann H., Kehm R., Kuhn J. E., Naher H., Kramer M. D., Braun R. W. 1991; Antigenic domains of the HIV-1 Vif protein as recognized by human sera and murine monoclonal antibodies. AIDS Research and Human Retroviruses 7:861–867
    [Google Scholar]
  20. Wieland U., Hartmann J., Suhr H., Salzberger B., Eggers H. J., Kuhn J. E. 1994; In vivo genetic variability of the HIV-1 vif gene. Virology 203:43–51
    [Google Scholar]
  21. Wilk T., Pfeiffer T., Bosch V. 1992; Retained in vitro infectivity and cytopathicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 189:167–177
    [Google Scholar]
  22. Willey R. L., Maldarelli F., Martin M. A., Strebel K. 1992; Human immunodeficiency vims type I Vpu protein induces rapid degradation of CD4. Journal of Virology 66:7193–7200
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-7-1389
Loading
/content/journal/jgv/10.1099/0022-1317-77-7-1389
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error